Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-03-29
2011-03-29
Fetterolf, Brandon J (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S687000
Reexamination Certificate
active
07915247
ABSTRACT:
Fenofibric acid formulations comprising 105 mg of fenofibric acid are described as well as methods of use thereof. Dosage forms include, for example, immediate-release dosage forms.
REFERENCES:
patent: 3053255 (1962-09-01), Meyer
patent: 3843480 (1974-10-01), Dreher
patent: 3948254 (1976-04-01), Zaffaroni
patent: 3948262 (1976-04-01), Zaffaroni
patent: 3993073 (1976-11-01), Zaffaroni
patent: 4310509 (1982-01-01), Berglund et al.
patent: 4485097 (1984-11-01), Bell
patent: 4505891 (1985-03-01), Ito
patent: 4542012 (1985-09-01), Dell
patent: 4560555 (1985-12-01), Snider
patent: 4597961 (1986-07-01), Etscorn
patent: 4608249 (1986-08-01), Otsuka et al.
patent: 4806356 (1989-02-01), Shaw
patent: 4940587 (1990-07-01), Jenkins et al.
patent: 5084278 (1992-01-01), Mehta
patent: 5178878 (1993-01-01), Wehling et al.
patent: 5800834 (1998-09-01), Spireas et al.
patent: 5968550 (1999-10-01), Spireas et al.
patent: 6096337 (2000-08-01), Spireas et al.
patent: 6197348 (2001-03-01), Morella et al.
patent: 6221392 (2001-04-01), Khankari et al.
patent: 6423339 (2002-07-01), Spireas
patent: 7022337 (2006-04-01), Liang et al.
patent: 7259186 (2007-08-01), Cink et al.
patent: 2003/0077297 (2003-04-01), Chen et al.
patent: 2003/0194442 (2003-10-01), Guivarch et al.
patent: 2003/0235595 (2003-12-01), Chen et al.
patent: 2005/0096390 (2005-05-01), Holm et al.
patent: 2005/0096391 (2005-05-01), Holm et al.
patent: 2005/0148594 (2005-07-01), Cink et al.
patent: 2005/0276974 (2005-12-01), Ryde et al.
patent: 2006/0068015 (2006-03-01), Holm et al.
patent: 2006/0105050 (2006-05-01), Holm et al.
patent: 2006/0110444 (2006-05-01), Holm et al.
patent: 2006/0134196 (2006-06-01), Rosenberg et al.
patent: 2006/0222706 (2006-10-01), Flashner-Barak et al.
patent: 2006/0222707 (2006-10-01), Lerner et al.
patent: 2006/0257470 (2006-11-01), Rosenberg et al.
patent: 2006/0280790 (2006-12-01), Ju et al.
patent: 2006/0280791 (2006-12-01), Ju et al.
patent: 2007/0009603 (2007-01-01), Holm et al.
patent: 2007/0014846 (2007-01-01), Holm et al.
patent: 2007/0015834 (2007-01-01), Flashner-Barak et al.
patent: 2007/0026062 (2007-02-01), Holm et al.
patent: 2007/0128278 (2007-06-01), Ju et al.
patent: 2007/0148233 (2007-06-01), Lerner et al.
patent: 2007/0148234 (2007-06-01), Ju et al.
patent: 2007/0185199 (2007-08-01), Ju et al.
patent: 2007/0190138 (2007-08-01), Holm
patent: 2007/0264334 (2007-11-01), Ju et al.
patent: 2008/0051411 (2008-02-01), Cink et al.
patent: 1829541 (2003-12-01), None
patent: 1572190 (2007-04-01), None
patent: 1832285 (2007-09-01), None
patent: 02067901 (2002-09-01), None
patent: 2004054568 (2004-07-01), None
patent: 2005034908 (2005-04-01), None
patent: 2005034920 (2005-04-01), None
patent: 2006037344 (2006-04-01), None
patent: 2006107316 (2006-10-01), None
patent: 2006107357 (2006-10-01), None
patent: 2006107411 (2006-10-01), None
patent: 2006135480 (2006-12-01), None
patent: 2008037809 (2008-04-01), None
Gilman et al ‘Goodman and Gilman's , The Pharmacological Basis of Therapeutics’ Pergamon Press, Eight Edition, 1992.
Ramana et al ‘Regulatory perspectives on in vitro (dissution)/ in vivo (bioavailability) correlations’ Journal of Controlled Release, vol. 72, p. 127-132, 2001.
Miller et al ‘Clinical Pharmacokinetics of Fibric Acid Derivatives (Fibrates)’ Clinical Pharmacokinetics, 34(2), p. 155-162, 1998.
Yu et al ‘Biopharmaceutical Classification System: The Scientific Basis for Biowaiver Extensions’ Pharmaceutical Research 19(7), p. 921-925, 2002.
Chiarla, et al.; “Severe Hypocholesterolemia in Surgical Patients, Sepsis, and Critical Illness”, Journal of Critical Care; Article in Press; 6 pages (2009).
Arnold Kristin Anne
Feng Hengsheng
Cantor & Colburn LLP
Fetterolf Brandon J
Mutual Pharmaceutical Company, Inc.
Stone Christopher R
LandOfFree
Methods of use of fenofibric acid does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of use of fenofibric acid, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of use of fenofibric acid will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2632159